RPG Life Sciences Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Yugal Kishor Sikri
Chief executive officer
₹47.8m
Total compensation
| CEO salary percentage | 69.5% |
| CEO tenure | 6.2yrs |
| CEO ownership | n/a |
| Management average tenure | 6.2yrs |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
There May Be Some Bright Spots In RPG Life Sciences' (NSE:RPGLIFE) Earnings
Nov 15
RPG Life Sciences Limited's (NSE:RPGLIFE) Shares Climb 26% But Its Business Is Yet to Catch Up
Oct 18Investors Appear Satisfied With RPG Life Sciences Limited's (NSE:RPGLIFE) Prospects As Shares Rocket 30%
Jul 25RPG Life Sciences' (NSE:RPGLIFE) Earnings Are Of Questionable Quality
May 08RPG Life Sciences (NSE:RPGLIFE) Is Increasing Its Dividend To ₹12.00
Jul 11Estimating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Sep 05Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now
Aug 24A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jun 14Are Strong Financial Prospects The Force That Is Driving The Momentum In RPG Life Sciences Limited's NSE:RPGLIFE) Stock?
Feb 09Can You Imagine How RPG Life Sciences' (NSE:RPGLIFE) Shareholders Feel About The 75% Share Price Increase?
Jan 13RPG Life Sciences (NSE:RPGLIFE) Is Growing Earnings But Are They A Good Guide?
Dec 23
Declining Stock and Solid Fundamentals: Is The Market Wrong About RPG Life Sciences Limited (NSE:RPGLIFE)?
Nov 11Estimating The Fair Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Oct 21Did Business Growth Power RPG Life Sciences' (NSE:RPGLIFE) Share Price Gain of 126%?
Sep 28What Makes RPG Life Sciences Limited (NSE:RPGLIFE) A Great Dividend Stock?
Aug 31With RPG Life Sciences Limited (NSE:RPGLIFE) It Looks Like You'll Get What You Pay For
Aug 11What You Can Learn From RPG Life Sciences Limited's (NSE:RPGLIFE) P/E
Jul 28Calculating The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)
Jul 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹707m |
| Jun 30 2024 | n/a | n/a | ₹923m |
| Mar 31 2024 | ₹48m | ₹33m | ₹877m |
| Dec 31 2023 | n/a | n/a | ₹848m |
| Sep 30 2023 | n/a | n/a | ₹774m |
| Jun 30 2023 | n/a | n/a | ₹715m |
| Mar 31 2023 | ₹39m | ₹27m | ₹676m |
| Dec 31 2022 | n/a | n/a | ₹648m |
| Sep 30 2022 | n/a | n/a | ₹603m |
| Jun 30 2022 | n/a | n/a | ₹561m |
| Mar 31 2022 | ₹39m | ₹27m | ₹515m |
| Dec 31 2021 | n/a | n/a | ₹509m |
| Sep 30 2021 | n/a | n/a | ₹491m |
| Jun 30 2021 | n/a | n/a | ₹445m |
| Mar 31 2021 | ₹39m | ₹24m | ₹400m |
| Dec 31 2020 | n/a | n/a | ₹361m |
| Sep 30 2020 | n/a | n/a | ₹311m |
| Jun 30 2020 | n/a | n/a | ₹297m |
| Mar 31 2020 | ₹22m | ₹21m | ₹290m |
| Dec 31 2019 | n/a | n/a | ₹276m |
| Sep 30 2019 | n/a | n/a | ₹249m |
| Jun 30 2019 | n/a | n/a | ₹173m |
| Mar 31 2019 | ₹22m | ₹11m | ₹108m |
| Dec 31 2018 | n/a | n/a | ₹105m |
| Sep 30 2018 | n/a | n/a | ₹107m |
| Jun 30 2018 | n/a | n/a | ₹149m |
| Mar 31 2018 | ₹375k | n/a | ₹135m |
Compensation vs Market: Yugal Kishor's total compensation ($USD560.21K) is above average for companies of similar size in the Indian market ($USD266.65K).
Compensation vs Earnings: Yugal Kishor's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Yugal Kishor Sikri (67 yo)
6.2yrs
Tenure
₹47,844,000
Compensation
Mr. Yugal Kishor Choturam Sikri has been Managing Director and Director at RPG Life Sciences Limited since October 1, 2018 He served as an Independent & Non-Executive Director at RPG Life Sciences Limited...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 6.2yrs | ₹47.84m | no data | |
| Chief Financial Officer | 4.3yrs | no data | no data | |
| Head of Legal | 13.1yrs | no data | no data | |
| Vice President of Sales & Marketing (Main Division) | no data | no data | no data | |
| Head of API Operations & Procurement | 7.7yrs | no data | no data | |
| Site Head of International Formulation | no data | no data | no data | |
| Chief Quality Officer | 5.9yrs | no data | no data |
6.2yrs
Average Tenure
Experienced Management: RPGLIFE's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Director | 8.4yrs | ₹47.84m | no data | |
| Chairman of the Board | 31yrs | ₹400.00k | 53.9% ₹ 18.9b | |
| Non-Executive Non-Independent Director | 20.4yrs | ₹400.00k | no data | |
| Non-Executive Director | 3.9yrs | ₹770.00k | no data | |
| Independent Non-Executive Director | 9.9yrs | ₹400.00k | 0.0089% ₹ 3.1m | |
| Independent & Non-Executive Director | 9.2yrs | ₹315.00k | no data | |
| Additional Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 5.2yrs | ₹530.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
6.8yrs
Average Tenure
56.5yo
Average Age
Experienced Board: RPGLIFE's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 16:35 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
RPG Life Sciences Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kunal Dhamesha | Emkay Global Financial Services Ltd. |
| Kameswari V. S. Chavali | FirstCall Research |